• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORCYM CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORCYM CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number TBD
Device Problem Detachment of Device or Device Component (2907)
Patient Problems Abscess (1690); Fever (1858)
Event Type  Injury  
Event Description
The manufacturer received information on this event through the publication ''mycobacterium chimaera.A lethal enemy of cardiac surgery'' by ferrer et al.Based on the information reported on the paper, due to symptomatic severe aortic stenosis and significant disease of the left anterior descending (lad) coronary artery, a patient underwent aortic valve replacement with a perceval s bioprosthesis and left internal mammary artery to lad coronary bypass graft in july 2016.Ten days after surgery, a ddd pacemaker was implanted due to complete atrioventricular block.In december 2016, the patient was hospitalized for prolonged fever with shivering, headache and abdominal discomfort.A transthoracic (tte) and transesophageal (tee) echocardiogram showed a normally functioning aortic bioprosthesis without images of vegetations or periannular complications.In july 2017, the patient was re-hospitalized because of febrile syndrome and dissociated cholestasis.A tee showed an heterogenous image at the posterior annulus in continuity with anterior mitral valve leaflet, compatible with periaortic abscess.A new fdg pet/ct scan was performed and confirmed morphologic and metabolic progression with respect to the previous study, without evidence of pacemaker infection.Decision for surgical re-intervention was made.Aortic bioprosthesis and pacemaker were both removed and a new perceval valve and an epicardial electrocatheter were implanted.The paper reports that ultimately the patient passed away (not related to the perceval valve implanted).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
CORCYM CANADA CORP.
5005 north fraser way
burnaby V5J 5 M1
CA  V5J 5M1
MDR Report Key12280624
MDR Text Key265160063
Report Number1718850-2021-01144
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeSP
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Reporter Occupation Physician
Type of Report Initial
Report Date 07/16/2021,08/05/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/05/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberTBD
Device Catalogue NumberTBD
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date07/16/2021
Event Location Hospital
Date Report to Manufacturer07/16/2021
Date Manufacturer Received07/16/2021
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age72 YR
-
-